Literature DB >> 25374901

Complications of initial prostate biopsy in a European randomized screening trial.

Suzanne van den Heuvel1, Stacy Loeb2, Xiaoye Zhu1, Paul Cms Verhagen1, Fritz H Schröder1, Chris H Bangma1, Monique J Roobol1.   

Abstract

BACKGROUND: Transrectal prostate needle biopsy (PNB) is a standard procedure for the diagnosis of prostate cancer. We recently found an increasing frequency of hospitalization with infectious complications associated with PNB over time.
OBJECTIVE: To perform an updated analysis of overall complication rates in a large screening population over the past 18 years and to examine possible predictors of complications on initial PNB. DESIGN, SETTING AND PARTICIPANTS: From 1993-2011, 7216 men underwent initial lateralized sextant PNB in European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam. After 2 weeks a questionnaire was administered to 6962 men regarding PNB-related complications. Outcome Measurements & Statistical Analysis: Overall complication rates as well as specific complications (hematuria for >3 days, hematospermia, significant pain after biopsy, fever, and hospitalizations) were prospectively recorded. Multivariable logistic regression models were performed to assess the relationship between age, comorbidities, and prostate volume with specific complications. RESULTS AND LIMITATIONS: A total of 4674 (67.1%) men reported any sequelae after initial PNB, with hematospermia as the most frequent (53.8%), followed by hematuria (24.3%). Significant pain (4.8%), fever (4.1%), and hospital admission (0.7%) were reported less frequently. Hematospermia was significantly more likely in younger men with fewer comorbidities and smaller prostate volume; whereas hematuria was significantly more frequent among men with increasing comorbidities and prostate volume. In addition, pain was inversely associated with age and was also reported less frequently during later years of biopsy. Limitations of our study include the use of sextant biopsies and a relatively healthy population, while strengths include the large sample size and data on patient-specific covariates.
CONCLUSION: Many men experience minor complications after initial PNB, although the frequency of specific complications such as hematospermia and hematuria differed based upon factors such as prostate volume and comorbidities. Overall, these data are useful to counsel patients who are undergoing their first PNB on the frequency of complications in a screening population.

Entities:  

Keywords:  Complications; prostate biopsy

Year:  2013        PMID: 25374901      PMCID: PMC4219277     

Source DB:  PubMed          Journal:  Am J Clin Exp Urol        ISSN: 2330-1910


  18 in total

Review 1.  The story of the European Randomized Study of Screening for Prostate Cancer.

Authors:  F H Schröder; L J Denis; M Roobol; V Nelen; A Auvinen; T Tammela; A Villers; X Rebillard; S Ciatto; M Zappa; A Berenguer; A Paez; J Hugosson; P Lodding; F Recker; M Kwiatkowski; W J Kirkels
Journal:  BJU Int       Date:  2003-12       Impact factor: 5.588

2.  Infectious complications and hospital admissions after prostate biopsy in a European randomized trial.

Authors:  Stacy Loeb; Suzanne van den Heuvel; Xiaoye Zhu; Chris H Bangma; Fritz H Schröder; Monique J Roobol
Journal:  Eur Urol       Date:  2012-01-05       Impact factor: 20.096

Review 3.  Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study.

Authors:  B Djavan; M Waldert; A Zlotta; P Dobronski; C Seitz; M Remzi; A Borkowski; C Schulman; M Marberger
Journal:  J Urol       Date:  2001-09       Impact factor: 7.450

4.  Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program.

Authors:  René Raaijmakers; Wim J Kirkels; Monique J Roobol; Mark F Wildhagen; Fritz H Schrder
Journal:  Urology       Date:  2002-11       Impact factor: 2.649

Review 5.  Risks and complications of transrectal ultrasound.

Authors:  L V Rodríguez; M K Terris
Journal:  Curr Opin Urol       Date:  2000-03       Impact factor: 2.309

6.  Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores.

Authors:  C K Naughton; D K Ornstein; D S Smith; W J Catalona
Journal:  J Urol       Date:  2000-01       Impact factor: 7.450

7.  Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores.

Authors:  Andreas P Berger; Christian Gozzi; Hannes Steiner; Ferdinand Frauscher; John Varkarakis; Hermann Rogatsch; Georg Bartsch; Wolfgang Horninger
Journal:  J Urol       Date:  2004-04       Impact factor: 7.450

8.  Low all-cause mortality in the volunteer-based Rotterdam section of the European randomised study of screening for prostate cancer: self-selection bias?

Authors:  S J Otto; F H Schröder; H J de Koning
Journal:  J Med Screen       Date:  2004       Impact factor: 2.136

9.  Patients' perceptions of transrectal prostate biopsy: a qualitative study.

Authors:  A B Chapple; S Ziebland; S Brewster; A McPherson
Journal:  Eur J Cancer Care (Engl)       Date:  2007-05       Impact factor: 2.520

10.  Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.

Authors:  Derek J Rosario; J Athene Lane; Chris Metcalfe; Jenny L Donovan; Andy Doble; Louise Goodwin; Michael Davis; James W F Catto; Kerry Avery; David E Neal; Freddie C Hamdy
Journal:  BMJ       Date:  2012-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.